MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 104 filers reported holding MERUS N V in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,644,344 | +31.9% | 239,370 | +47.3% | 0.04% | +18.9% |
| Q2 2023 | $4,278,650 | +236.2% | 162,501 | +135.0% | 0.04% | +208.3% |
| Q1 2023 | $1,272,525 | +81.3% | 69,159 | +52.5% | 0.01% | +100.0% |
| Q4 2022 | $701,719 | -73.1% | 45,360 | -65.2% | 0.01% | -72.7% |
| Q3 2022 | $2,611,000 | -19.3% | 130,392 | -8.7% | 0.02% | -29.0% |
| Q2 2022 | $3,235,000 | +44.4% | 142,878 | +68.6% | 0.03% | +55.0% |
| Q1 2022 | $2,240,000 | +31.7% | 84,723 | +58.4% | 0.02% | +33.3% |
| Q4 2021 | $1,701,000 | – | 53,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 893,527 | $23,625,000 | 21.94% |
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $42,304,000 | 11.46% |
| COMMODORE CAPITAL LP | 1,816,421 | $48,026,000 | 10.73% |
| MPM BioImpact LLC | 919,482 | $24,311,000 | 6.52% |
| Aquilo Capital Management, LLC | 1,261,534 | $33,355,000 | 4.90% |
| BVF INC/IL | 4,135,071 | $109,331,000 | 4.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 324,719 | $8,586,000 | 3.55% |
| TCG Crossover Management, LLC | 300,000 | $7,932,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 235,500 | $6,227,000 | 2.91% |
| Opaleye Management Inc. | 338,000 | $8,937,000 | 2.78% |